Main Menu
Main Menu
MyTumorID helps you understand what biomarker testing is and why identifying your tumor at the molecular level matters. When you ID your tumor, you can explore treatment options with your health care team and make informed decisions about your care, including whether a clinical trial may be right for you. With MyTumorID, I decide.
Sign up to receive information about biomarker testing, clinical trials, and more, including updates and educational resources, delivered straight to your inbox.
Clinical trials are a recommended initial treatment option after surgery for many brain tumor types, according to NCCN’s 2023 guidelines.
Only about 8% of people with cancer participate in a clinical trial, according to an ACS-CAN landscape report.
The most recent updates to the classification of brain tumors emphasizes the importance of biomarker testing in the diagnosis of brain tumors.
Learn About Biomarker TestingBiomarker testing changed everything. By knowing my diagnosis and treatment options, I felt like I had a sense of control. It completely changed the trajectory of treatment and my life.
Ben S-L., high-grade brainstem glioma
Have you undergone biomarker testing for your brain tumor or enrolled in a clinical trial? NBTS wants to hear from you!
Want to get involved? Help us raise awareness by sharing the infoboxes below about biomarker testing and clinical trials with your social networks and health organizations. Also keep an eye on our NBTS channels to reshare our posts about MyTumorID topics. All patients and their care partners deserve to be equipped with the tools they need to make the best decisions for their care.
Read stories featuring members of the brain tumor community and the latest educational resources and news about biomarker testing and clinical trials.
